Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.

Suppr

超能文献

作者信息

Crook T

出版信息

Psychopharmacol Bull. 1988;24(1):31-8.

PMID:3290945

Abstract

摘要

相似文献

Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.

Psychopharmacol Bull. 1988;24(1):31-8.

Memory problems in dementia: adaptation and coping strategies and psychosocial treatments.

Expert Rev Neurother. 2011 Dec;11(12):1769-81; quiz 1782. doi: 10.1586/ern.11.167.

Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.

Neurobiol Aging. 2004 Mar;25(3):311-4. doi: 10.1016/S0197-4580(03)00087-3.

Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.

Psychiatry Clin Neurosci. 2005 Dec;59(6):697-704. doi: 10.1111/j.1440-1819.2005.01439.x.

Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.

Prog Clin Biol Res. 1989;317:1111-20.

Rofecoxib in mild cognitive impairment.

Curr Psychiatry Rep. 2006 Feb;8(1):9-10.

Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment.

Neurology. 2005 Jun 28;64(12):2063-8. doi: 10.1212/01.WNL.0000165995.98986.F1.

[News on the Alzheimer's disease].

Ann Pharm Fr. 2009 Mar;67(2):67-8. doi: 10.1016/j.pharma.2008.12.001. Epub 2009 Jan 29.

Galantamine for Alzheimer's disease and mild cognitive impairment.

Neuroepidemiology. 2007;28(2):116-7. doi: 10.1159/000101510. Epub 2007 Apr 4.

[Awareness of memory deficits in patients with probable Alzheimer's disease].

Fortschr Neurol Psychiatr. 2005 Jun;73(6):327-32. doi: 10.1055/s-2004-830245.

引用本文的文献

Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies.

Drugs Aging. 1995 Dec;7(6):459-79. doi: 10.2165/00002512-199507060-00006.

Ginkgo biloba extract and cognitive decline.

Br J Clin Pharmacol. 1993 Aug;36(2):137. doi: 10.1111/j.1365-2125.1993.tb04213.x.

Tetrahydroaminoacridine (THA) in Alzheimer's disease.

BMJ. 1989 Apr 1;298(6677):845-6. doi: 10.1136/bmj.298.6677.845.

Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.

BMJ. 1990 Apr 28;300(6732):1132-3; discussion 1131. doi: 10.1136/bmj.300.6732.1132.

Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive decline.

Drugs Aging. 1992 May-Jun;2(3):153-73. doi: 10.2165/00002512-199202030-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验